Evidence map›Paper›PMID 41861179›Full record

ArticleMedicine2026

Psoriasis to psoriatic arthritis in terms of complement proteins: A single center experience.

Evren Er, Nurce Cilesizoglu Yavuz, Ilker Fatih Sari, Fazil Kulakli, Sevgi Kulakli

Abstract read
In one paragraph

Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Evren ErDepartment of Physical Medicine and Rehabilitation, Giresun University Faculty of Medicine, Giresun, Center of Giresun, Turkey.
Nurce Cilesizoglu YavuzDepartment of Physical Medicine and Rehabilitation, Giresun University Faculty of Medicine, Giresun, Center of Giresun, Turkey.ORCID 0000-0002-0122-6058
Ilker Fatih SariDepartment of Physical Medicine and Rehabilitation, Giresun University Faculty of Medicine, Giresun, Center of Giresun, Turkey.
Fazil KulakliDepartment of Physical Medicine and Rehabilitation, Giresun University Faculty of Medicine, Giresun, Center of Giresun, Turkey.
Sevgi KulakliDepartment of Dermatology, Giresun University Faculty of Medicine, Giresun, Center of Giresun, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are previously stated risk factors for the transition from psoriasis to psoriatic arthritis, but the immune mechanisms in this regard have not been adequately explained. In this study, we aimed to investigate this transition in terms of the complement system. Study was planned as a prospective analytical type. 46 psoriasis and 45 psoriatic arthritis patients were included in this study. Morning stiffness, nail involvement, disease activation questionnaire scores, neutrophil and lymphocyte percentage, neutrophil-lymphocyte rate, high-density lipoprotein, low-density lipoprotein, triglyceride, erythrocyte sedimentation rate, C-reactive protein, uric acid, complement 3 (C3) and 4 (C4) values were evaluated. Enthesis clinical assessment was done with the Leeds enthesis index (LEI). Ultrasonography was used to evaluate the enthesis sites. The severity of skin involvement in psoriasis was evaluated with the psoriasis area severity index (PASI). PASI scores were higher in psoriasis patients, while LEI scores, erythrocyte sedimentation rate and C-reactive protein levels were higher in psoriatic arthritis patients (P = .016, P = <.001, P = .016, P = .027, P = .020, respectively). Among psoriasis patients, C3 levels were higher in the patients with nail involvement (P = .035). C3 levels of psoriasis patients showed a moderate positive correlation between PASI and LEI scores (r = 0.368, r = 0.404, respectively). In psoriasis patients, high-density lipoprotein values were found to be moderately negatively correlated with both C3 and C4 (r = -0.311, r = -0.388, respectively). As a result of this study, C3 levels may play a role in the progression to psoriatic arthritis.

Indexed as

Arthritis, PsoriaticComplement C3Complement System ProteinsPsoriasisAdultBlood SedimentationComplement C4C-Reactive ProteinDisease ProgressionFemaleHumansMaleMiddle AgedProspective StudiesSeverity of Illness IndexComplement C3Complement C4Complement System ProteinsC-Reactive Proteincomplement 3complement 4psoriasispsoriatic arthritis

Identifiers

PMID41861179
PMCPMC13008142

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.